Catalyst Pharmaceuticals Inc (CPRX)
15.48
+0.14
(+0.91%)
USD |
NASDAQ |
Apr 19, 14:08
Catalyst Pharmaceuticals Cash from Investing (TTM): -293.50M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -293.50M |
September 30, 2023 | -255.18M |
June 30, 2023 | -162.50M |
March 31, 2023 | -153.16M |
December 31, 2022 | 9.209M |
September 30, 2022 | 9.168M |
June 30, 2022 | 9.232M |
March 31, 2022 | -4.11M |
December 31, 2021 | -11.02M |
September 30, 2021 | -10.98M |
June 30, 2021 | -20.92M |
March 31, 2021 | -16.92M |
December 31, 2020 | -5.011M |
September 30, 2020 | 26.65M |
June 30, 2020 | 41.71M |
March 31, 2020 | 31.78M |
December 31, 2019 | 37.22M |
September 30, 2019 | 19.71M |
June 30, 2019 | 22.24M |
March 31, 2019 | 27.21M |
December 31, 2018 | -15.08M |
September 30, 2018 | -29.17M |
June 30, 2018 | -36.77M |
March 31, 2018 | -31.82M |
December 31, 2017 | -0.004M |
Date | Value |
---|---|
September 30, 2017 | 0.5217M |
June 30, 2017 | 2.751M |
March 31, 2017 | 3.585M |
December 31, 2016 | 3.553M |
September 30, 2016 | 3.017M |
June 30, 2016 | 0.7732M |
March 31, 2016 | -0.0288M |
December 31, 2015 | -0.0065M |
September 30, 2015 | -0.0659M |
June 30, 2015 | -0.0064M |
March 31, 2015 | -10.05M |
December 31, 2014 | -8.741M |
September 30, 2014 | -15.54M |
June 30, 2014 | -19.75M |
March 31, 2014 | -7.717M |
December 31, 2013 | -7.497M |
September 30, 2013 | -14.74M |
June 30, 2013 | -10.55M |
March 31, 2013 | -12.57M |
December 31, 2012 | -14.06M |
September 30, 2012 | 1.995M |
June 30, 2012 | 1.993M |
March 31, 2012 | -0.0086M |
December 31, 2011 | -0.0036M |
September 30, 2011 | -2.008M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-293.50M
Minimum
Dec 2023
41.71M
Maximum
Jun 2020
-38.23M
Average
-4.11M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
Pfizer Inc | -32.28B |
Sarepta Therapeutics Inc | -165.80M |
PTC Therapeutics Inc | -176.74M |
Corcept Therapeutics Inc | 90.91M |
Cytokinetics Inc | 239.25M |